InvestorsHub Logo
Followers 247
Posts 13739
Boards Moderated 0
Alias Born 05/19/2015

Re: 29YEARINVESTOR post# 107818

Tuesday, 04/26/2022 7:46:25 AM

Tuesday, April 26, 2022 7:46:25 AM

Post# of 118425
RGBP I’m in It To Win It!
Great Job Dr. KOO’s
https://docoh.com/news/benzinga/26172220/regen-biopharma-inc?fromCompany=1589150
During the quarter ended June 30, 2021 the Company was paid $1,905,000 in cash and securities resulting from two licenses granted in April, 2021 to Oncology Pharma, Inc. ("ONPH").
Pursuant to the terms and conditions of the licenses granted ONPH became obligated to:
(a) Pay nonrefundable fees of $55,000 and fifty thousand common shares of ONPH no later than April 20, 2021
(b) Pay royalties equal to five percent (5%) of the Net Sales (as Net Sales are defined in the Agreement) of any Licensed Products in a quarter.